SANUWAVE Health SNWV
Sanuwave Health reported Q3 2026 results
SANUWAVE Health (SNWV) filed an 8-K with the SEC on Nov 10, 2026, 5:09 pm ET. Source: the filing on SEC EDGAR.
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001628280-26-072832
- Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025.
- GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 million in Q3 2025.
- Net loss for Q3 2026 was $1.4 million compared to net income of $9.7 million in Q3 2025.
- Ultramist® systems sold dropped to 40 in Q3 2026 from 155 in Q3 2025.
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
